WeVote

Bill

Bill

LD 1007

An Act To Update The State'S Informed Consent Laws Regarding Drug-Induced Abortion

132nd Legislature (2025-2026) Introduced by Alicia Collins and 7 co-sponsors

Maine Senate rejected LD 1007, which would have updated informed consent requirements for medication abortion, in a 21-13 vote.

Placed in Legislative Files (DEAD)
0
WeVote Research Nonpartisan
Bill Summary · LD 1007

Legislative bill overview

LD 1007 proposed updating Maine's informed consent requirements for medication abortion (drug-induced abortion). The bill was introduced in the 2025 legislative session but was rejected by the Maine Senate on June 10, 2025, with a 21-13 vote against passage.

Why is this important

Informed consent laws directly affect what information patients must receive before obtaining abortion services and can significantly impact access to medication abortion care. Changes to these requirements influence both patient autonomy and the practical availability of this abortion method in the state.

Potential points of contention

  • Medical accuracy vs. regulatory burden: Debates over whether proposed consent requirements reflect current medical evidence or impose unnecessary procedural obstacles
  • Timing and disclosure details: Disagreement about what information must be disclosed, when it must be provided, and whether waiting periods should apply to medication abortion specifically
  • Access implications: Concern that stricter informed consent requirements could delay care or create barriers for patients in underserved areas or with limited resources

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.